BioPharma Credit PLC
BPCP.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £1 | £1 | £1 | £1 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £1 | £1 | £1 | £1 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -8.3% | -26.3% | 109.4% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | £0 | £0 | £0 | £0 |
| % Margin | 98.2% | 0% | 0% | 0% |
| Net Income | £0 | £0 | £0 | £0 |
| % Margin | 98.2% | 79.9% | 99% | 96.6% |
| EPS Diluted | 0.1 | 0.083 | 0.13 | 0.062 |
| % Growth | 20.8% | -36.3% | 110.4% | – |
| Operating Cash Flow | £0 | £0 | £0 | £0 |
| Capital Expenditures | £0 | £0 | £0 | £0 |
| Free Cash Flow | £0 | £0 | £0 | £0 |